TFBG showed strong affinity for the PLK1 binding pocket, thereby blocking SHCBP1 and PLK1 association, which led to cancer growth inhibition and enhanced sensitivity to trastuzumab resistance in gastric cancer. This evidence concerns the gene SHCBP1 and gastric cancer.